WO2021046678A1 - 一种合成鹅去氧胆酸的方法及其应用 - Google Patents
一种合成鹅去氧胆酸的方法及其应用 Download PDFInfo
- Publication number
- WO2021046678A1 WO2021046678A1 PCT/CN2019/104895 CN2019104895W WO2021046678A1 WO 2021046678 A1 WO2021046678 A1 WO 2021046678A1 CN 2019104895 W CN2019104895 W CN 2019104895W WO 2021046678 A1 WO2021046678 A1 WO 2021046678A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound represented
- chenodeoxycholic acid
- synthesizing
- acid according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Definitions
- the invention relates to the technical field of the synthesis of pharmaceutical and chemical products, in particular to a method for preparing chenodeoxycholic acid by chemical synthesis and its application.
- Chenodeoxycholic acid whose chemical name is 3 ⁇ ,7 ⁇ -dihydroxy-5- ⁇ -cholanoic acid, is a natural primary bile acid. It is widely present in the bile of humans, livestock and poultry, such as chickens, ducks, geese, etc. The main component in poultry bile was first discovered in goose bile in 1848, so it was named chenodeoxycholic acid, also known as deoxychenoderic acid, and the English name is Chenodeoxycholic Acid, abbreviated as CDCA.
- chenodeoxycholic acid can reduce the synthesis and secretion of cholesterol, reduce the excretion of total cholesterol in the bile, thereby improving the ability of bile to dissolve cholesterol, and promote the dissociation of cholesterol in the stone to achieve the stone-dissolving effect.
- UDCA ursodeoxycholic acid
- the methods for producing chenodeoxycholic acid mainly include extraction and synthesis.
- the extraction method refers to the direct extraction of chenodeoxycholic acid from the bile of poultry or livestock. This method has the disadvantages of complex extraction process, low yield, and many impurity components, and cannot meet the needs of large-scale industrial production.
- the most widely used synthetic methods in industry mainly use cholic acid (CA), deoxycholic acid (DCA), hyodeoxycholic acid (HDCA), etc. as starting materials, and prepare chenodeoxycholic acid through organic chemical conversion.
- Chinese invention patent application CN107383137A discloses a method for synthesizing chenodeoxycholic acid using cholic acid as a raw material
- Chinese invention patent application CN106831923A discloses a method for preparing chenodeoxycholic acid using hyodeoxycholic acid as a raw material, etc. .
- these existing synthesis methods are often costly and need to be further improved to reduce production costs.
- Seal cholic acid is called Phocacholic Acid in English and PCA for short. According to market research, it is found that the annual output of seal cholic acid is large, with a wide range of market sources and low prices. Compared with the chemical structure of chenodeoxycholic acid, seal cholic acid only has one more hydroxyl group at position 23 on the side chain. The skeletons and substituent configurations of the two are exactly the same. However, so far, seal cholic acid has not been seen as The industrial application of starting materials to synthesize chenodeoxycholic acid and other related reports.
- seal cholic acid can be used to synthesize chenodeoxycholic acid
- a synthetic process for producing chenodeoxycholic acid from seal cholic acid can be developed, which can expand the application range of seal cholic acid and increase the market value of seal cholic acid. It can also reduce the production cost of chenodeoxycholic acid and has great market prospects.
- the present invention aims to solve the technical problem of high production cost in the existing methods for producing chenodeoxycholic acid, thereby providing a seal urchin with a wide range of sources and low prices.
- a chemical synthesis method for the production of chenodeoxycholic acid with acid as the starting material is a chemical synthesis method for the production of chenodeoxycholic acid with acid as the starting material.
- R 1 is preferably a methyl group or an ethyl group.
- R 2 is preferably an acetyl group.
- the compound represented by formula 1 undergoes a chemical reaction under the action of methanol or ethanol and a catalyst, and is converted into the compound represented by formula 2.
- the catalyst used in the reaction of converting the compound represented by formula 1 into the compound represented by formula 2 is concentrated sulfuric acid, concentrated hydrochloric acid or p-toluenesulfonate acid.
- the chemical reaction temperature for converting the compound represented by formula 1 into the compound represented by formula 2 is 60-80°C
- the optimal chemical reaction temperature for converting the compound represented by formula 1 into the compound represented by formula 2 is 60- 65°C.
- the compound represented by formula 2 undergoes a chemical reaction under the action of acetic anhydride, propionic anhydride or butyric anhydride, and is converted into the compound represented by formula 3.
- the compound represented by Formula 2 undergoes a chemical reaction under the action of acetic anhydride and is converted into the compound represented by Formula 3.
- acetic anhydride Compared with propionic anhydride or butyric anhydride, the use of acetic anhydride has the beneficial effects of higher reactivity and shorter reaction time without affecting selectivity, and acetic anhydride is inexpensive and has a wide range of sources.
- the reaction solvent for the chemical reaction of converting the compound represented by formula 2 into the compound represented by formula 3 is an aprotic solvent.
- the aprotic solvent referred to in the present invention refers to a solvent with extremely weak proton autotransmission reaction or no autotransmission tendency, including toluene, methylene chloride, tetrahydrofuran, pyridine, etc., also known as aprotic solvent, aprotic solvent or aprotic Pass the solvent.
- the reaction solvent for the chemical reaction of converting the compound represented by formula 2 into the compound represented by formula 3 is pyridine, which is compared with other applicable aprotic compounds.
- the solvent, pyridine has better solubility for the reaction substrate, which is beneficial to accelerate the progress of the chemical reaction.
- the chemical reaction temperature for converting the compound represented by formula 2 into the compound represented by formula 3 is 100-110°C.
- R 3 is preferably a halogen.
- halogen has a better leaving effect, so that the substrate conversion rate is higher, and it is easy to directly remove by direct hydrogenolysis reduction.
- the subsequent conversion process from the compound represented by formula 4 to the compound represented by formula 5 is simpler and easier to operate, and more environmentally friendly.
- the compound represented by formula 3 and the halogenating reagent undergo a chemical reaction to convert into the compound represented by formula 4, wherein the halogen Substitution reagents are thionyl chloride, sulfonyl chloride or phosphorus halide.
- the halogenating reagent is thionyl chloride.
- the by-products produced when thionyl chloride is used to participate in the reaction are easier to handle, which is more economical and environmentally friendly.
- the chemical reaction between the compound represented by formula 3 and the halogenating reagent is in toluene, dichloromethane, chloroform, 1 , 4-Dioxane and pyridine in one or more reaction solvents.
- the reaction solvent for the chemical reaction between the compound represented by formula 3 and the halogenated reagent is dichloromethane.
- dichloromethane has the advantages of low boiling point and easy recovery.
- the reaction rate of converting the compound represented by formula 3 into the compound represented by formula 4 is greatly affected by the reaction temperature, and the reaction temperature is too low.
- the reaction is slower and time-consuming, and if the reaction temperature is too high, side reactions will increase. Therefore, the reaction temperature is preferably 35-40°C.
- R 3 is a halogen
- the compound represented by formula 4 undergoes a dehydrohalogenation hydrogenolysis reaction under the action of a hydrogen donor and palladium carbon, and is converted into The compound represented by formula 5, wherein the hydrogen donor is hydrogen gas or ammonium formate, the dehydrohalogenation hydrogenolysis reaction has the advantages of simplicity and simplicity and simple post-processing.
- the hydrogen donor is preferably ammonium formate, which has the advantages of mild reaction conditions and high safety.
- the reaction temperature of the dehydrohydrogenolysis reaction of the compound represented by formula 4 being converted into the compound represented by formula 5 is 50-65°C.
- R 3 is a p-toluenesulfonate group or a mesylate group
- the compound represented by formula 3 is in toluenesulfonyl chloride or methanesulfonyl chloride
- a chemical reaction occurs and it is converted into a compound represented by formula 4, wherein the organic base is pyridine, triethylamine, N,N-diisopropylethylamine or 4-dimethylaminopyridine.
- R 3 is a p-toluenesulfonate group or a mesylate group
- the compound represented by formula 3 is in the combination of methanesulfonyl chloride and pyridine Under the action, a chemical reaction occurs and it is transformed into the compound shown in formula 4.
- the compound represented by formula 5 undergoes a deprotection reaction under the action of an inorganic base, and is converted into chenodeoxycholic acid represented by formula 6.
- the inorganic base used in the deprotection reaction of the compound represented by formula 5 is sodium hydroxide. Compared with other inorganic bases, sodium hydroxide The price is low, the source is wide, and the production cost is lower.
- the deprotection reaction temperature of the compound represented by formula 5 into the chenodeoxycholic acid represented by formula 6 is 60-80°C.
- the reaction solvent for the deprotection reaction of converting the compound represented by formula 5 into chenodeoxycholic acid represented by formula 6 is methanol or ethanol.
- the present invention also provides the application of the method for synthesizing chenodeoxycholic acid in the preparation of ursodeoxycholic acid and its derivatives, that is, preparing chenodeoxycholic acid by referring to the method for synthesizing chenodeoxycholic acid provided by the present invention.
- Cholic acid and then use the prepared chenodeoxycholic acid as a raw material to prepare ursodeoxycholic acid and its derivatives.
- the present invention also provides a new use of seal cholic acid, that is, as a raw material for the synthesis of chenodeoxycholic acid.
- the method for synthesizing chenodeoxycholic acid uses seal cholic acid with a wide source, large market supply and low price as the starting material, which can reduce the production cost to a greater extent, and the
- the reagents used in the method are all conventional reagents, the process is simple and easy to operate, the product conversion rate is high, and it has extremely high industrial application value and economic value.
- the method of the present invention also expands the application range of seal cholic acid and improves the market value of seal cholic acid.
- the best implementation of the method for synthesizing chenodeoxycholic acid includes the following steps:
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (15)
- 根据权利要求2所述的合成鹅去氧胆酸的方法,其特征在于:式1所示的化合物在甲醇或乙醇以及催化剂的作用下发生化学反应,转化成式2所示的化合物。
- 根据权利要求3所述的合成鹅去氧胆酸的方法,其特征在于:式1所示的化合物转化成式2所示的化合物的化学反应温度为60-80℃。
- 根据权利要求2所述的合成鹅去氧胆酸的方法,其特征在于:式2所示的化合物在乙酸酐、丙酸酐或者丁酸酐的作用下发生化学反应,转化成式3所示的化合物。
- 根据权利要求5所述的合成鹅去氧胆酸的方法,其特征在于:式2所示的化合物转化成式3所示的化合物的化学反应温度为100-110℃。
- 根据权利要求1或2所述的合成鹅去氧胆酸的方法,其特征在于:所述R 3为卤素。
- 根据权利要求7所述的合成鹅去氧胆酸的方法,其特征在于:式3所示的化合物与卤代试剂发生化学反应转化成式4所示的化合物,所述卤代试剂为氯化亚砜、磺酰氯或卤化磷。
- 根据权利要求8所述的合成鹅去氧胆酸的方法,其特征在于:式3所示的化合物转化成式4所示的化合物的的化学反应温度为35-40℃。
- 根据权利要求8所述的合成鹅去氧胆酸的方法,其特征在于:式4所示的化合物在供氢体和钯碳的作用下发生脱卤氢解反应,转化成式5所 示的化合物。
- 根据权利要求10所述的合成鹅去氧胆酸的方法,其特征在于:式4所示的化合物转化成式5所示的化合物的脱卤氢解反应的反应温度为50-65℃。
- 根据权利要求1或2所述的合成鹅去氧胆酸的方法,其特征在于:所述R 3为甲苯磺酸酯基或甲磺酸酯基,式3所示的化合物在甲苯磺酰氯或甲磺酰氯以及有机碱的作用下发生化学反应,转化成式4所示的化合物。
- 根据权利要求1或2所述的合成鹅去氧胆酸的方法,其特征在于:式5所示的化合物转化成式6所示的鹅去氧胆酸的脱保护反应的温度为60-80℃。
- 权利要求1或2所述的合成鹅去氧胆酸的方法在制备熊去氧胆酸及其衍生物中的应用。
- 海豹胆酸在合成鹅去氧胆酸中的应用。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/104895 WO2021046678A1 (zh) | 2019-09-09 | 2019-09-09 | 一种合成鹅去氧胆酸的方法及其应用 |
CN201980042284.1A CN112334476B (zh) | 2019-09-09 | 2019-09-09 | 一种合成鹅去氧胆酸的方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/104895 WO2021046678A1 (zh) | 2019-09-09 | 2019-09-09 | 一种合成鹅去氧胆酸的方法及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021046678A1 true WO2021046678A1 (zh) | 2021-03-18 |
Family
ID=74319825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/104895 WO2021046678A1 (zh) | 2019-09-09 | 2019-09-09 | 一种合成鹅去氧胆酸的方法及其应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112334476B (zh) |
WO (1) | WO2021046678A1 (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1869043A (zh) * | 2006-06-09 | 2006-11-29 | 沈阳化工学院 | 一种鹅去氧胆酸的合成方法 |
CN101434632A (zh) * | 2008-12-16 | 2009-05-20 | 同济大学 | 一种3α,7α-二羟基-5β-胆烷酸的制备方法 |
CN106883281A (zh) * | 2017-03-08 | 2017-06-23 | 眉山市新功生物科技有限公司 | 从鸭胆汁中提取鹅去氧胆酸的方法 |
CN107771180A (zh) * | 2015-06-19 | 2018-03-06 | 英特塞普特医药品公司 | Tgr5调节剂及其使用方法 |
CN109762043A (zh) * | 2019-03-06 | 2019-05-17 | 华南理工大学 | 鹅去氧胆酸及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA200101157A1 (ru) * | 1999-05-10 | 2002-06-27 | Шеринг Акциенгезельшафт | 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ |
CN103613628B (zh) * | 2013-11-07 | 2015-04-22 | 浙江大学 | 25-羟基胆固醇的生产方法 |
-
2019
- 2019-09-09 CN CN201980042284.1A patent/CN112334476B/zh active Active
- 2019-09-09 WO PCT/CN2019/104895 patent/WO2021046678A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1869043A (zh) * | 2006-06-09 | 2006-11-29 | 沈阳化工学院 | 一种鹅去氧胆酸的合成方法 |
CN101434632A (zh) * | 2008-12-16 | 2009-05-20 | 同济大学 | 一种3α,7α-二羟基-5β-胆烷酸的制备方法 |
CN107771180A (zh) * | 2015-06-19 | 2018-03-06 | 英特塞普特医药品公司 | Tgr5调节剂及其使用方法 |
CN106883281A (zh) * | 2017-03-08 | 2017-06-23 | 眉山市新功生物科技有限公司 | 从鸭胆汁中提取鹅去氧胆酸的方法 |
CN109762043A (zh) * | 2019-03-06 | 2019-05-17 | 华南理工大学 | 鹅去氧胆酸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112334476A (zh) | 2021-02-05 |
CN112334476B (zh) | 2022-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2576922C (en) | Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether | |
DK2428519T3 (en) | A composition for the preparation of 17-vinyl triflates as intermediates | |
WO2021258723A1 (zh) | 一种以ba为原料合成石胆酸的方法 | |
EP1903050B1 (en) | A process for the preparation of cholanic acids | |
TWI530504B (zh) | 烷基酸睾酮化合物之合成方法 | |
CN107698538B (zh) | 罗沙替丁醋酸酯盐酸盐的中间体3-(1-哌啶甲基)苯酚的制备方法 | |
WO2021046678A1 (zh) | 一种合成鹅去氧胆酸的方法及其应用 | |
CN113845485B (zh) | 氨基酸衍生物及其制备方法和应用 | |
CN115466300A (zh) | 一种胆酸中间体a7及其合成方法 | |
CN107383137A (zh) | 一种鹅去氧胆酸的合成方法 | |
CN113461764A (zh) | 一种熊去氧胆酸的合成方法 | |
CN107663221A (zh) | 一种奥贝胆酸的制备方法 | |
Hitchin et al. | A novel scalable and stereospecific synthesis of 3α-and 3β-amino-5α-androstan-17-ones and 3α-and 3β-amino-5α-pregnan-20-ones | |
RU2103275C1 (ru) | Производные 17-галоген-4-азаандростена | |
CN115611961B (zh) | 胆酸中间体a2及其制备方法 | |
CN112390840B (zh) | 一种3β-乙酰氧基雄甾-5-烯-17-酮的制备方法 | |
CN114940695B (zh) | 一种具有抗肿瘤活性的雄诺龙衍生物及其制备方法与应用 | |
EP2044098A2 (en) | Process for the preparation of 6-alpha ,9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-3-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl ester | |
CN107021994B (zh) | 一种奥贝胆酸的中间体3α-羟基-7-酮-5β-胆甾烷-24-酸的合成方法 | |
JP2001261696A (ja) | ウルソデオキシコール酸の第三級アミン塩及びこれを利用したウルソデオキシコール酸の製造方法 | |
JP2023542365A (ja) | タウロデオキシコール酸ナトリウムの大量生産方法 | |
CN115651049A (zh) | 胆酸中间体a3及其制备方法 | |
CN112745370A (zh) | 一种泰拉霉素的制备方法 | |
CN109734765A (zh) | 一种17a-脱羟醋酸泼尼松龙产品的制备方法 | |
CN108794558A (zh) | 一种反应条件温和的奥贝胆酸制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19945271 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19945271 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 29/08/2022) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19945271 Country of ref document: EP Kind code of ref document: A1 |